Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Chen Z, Moayeri M, Purcell R. Monoclonal antibody therapies against anthrax. Toxins. 2011;3(8):1004–19.
2. Hendricks KA, Wright ME, Shadomy SV, et al. Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emerg Infect Dis. 2014;20(2):[article no. e130687].
3. US Food and Drug Administration. FDA approves new treatment for inhalation anthrax [media release]. 21 March 2016. http://www.fda.gov .
4. Elusys Therapeutics Inc. Anthim® (obiltoxaximab) injection, for intravenous use: US prescribing Information. 2016. http://www.fda.gov . Accessed 23 Mar 2016.
5. Elusys Therapeutics Inc. Elusys CEO to testify on biodefense before house subcommittee [media release]. 21 Oct 2001. http://www.prnewswire.com .
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献